23
Participants
Start Date
July 31, 2014
Primary Completion Date
January 28, 2016
Study Completion Date
January 28, 2016
Eribulin Mesylate
Eribulin mesylate will be administered intravenously on Days 1 and 8 of each 21-day cycle.
Childrens Hospital of Philadelphia, Philadelphia
Columbia University Medical Center, New York
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Children's National Medical Center, Washington D.C.
Children's Healthcare of Atlanta - Egleston, Atlanta
Children's Hospital of Alabama, Birmingham
St. Jude Children's Research Hospital, Memphis
Cincinnati Children's Hospital Medical Center, Cincinnati
Riley Hospital for Children, Indianapolis
C S Mott Children's Hospital, Ann Arbor
Midwest Children's Cancer Center, Milwaukee
University of Minnesota Cancer Center-Fairview, Minneapolis
Washington University School of Medicine, St Louis
Baylor College of Medicine, Houston
Childrens Hospital of Orange County, Orange
UCSF Medical Center-Parnassus, San Francisco
Oregon Health and Science University, Portland
Seattle Children's Hospital, Seattle
Children's Oncology Group
NETWORK
Eisai Inc.
INDUSTRY